Aims-To define and group static and dynamic iliac crest histomorphometric parameters in women with established osteoporosis. Methods-Iliac crest biopsy specimens from 146 white women were sectioned undecalcified and examined using image analysis. Results-Five distinct groups were defined on the basis of histomorphometric changes in cell function: group 1, decreased osteoblastic and osteoclastic activity; group 2, decreased osteoblastic and increased osteoclastic activity; group 3, increased osteoblastic and osteoclastic activity; group 4, no bone surface cell activity; and group 5, apparently normal osteoblastic and osteoclastic activity. Conclusions-Five distinct subgroups of patients with postmenopausal osteoporosis can be defined based on changes in bone cell function. Defining cellular dysfunction in this way may be important for tailoring treatment regimens to the needs of individual patients. (7 Clin Pathol 1995;48:229-235) 
The clinical syndrome of osteoporosis is a common manifestation of a variety of disorders. At the cellular level, the syndrome can be broadly regarded as an imbalance or uncoupling of osteoblastic bone deposition and osteoclastic bone resorption.' Theoret- ically, this imbalance may take several forms ranging from an increase in both osteoclasis and osteoblastic activity, with a greater increase in the former,2 to a decrease in both, with a greater reduction in osteoblastic activity. 34 Studies of postmenopausal osteoporosis suggest that there is heterogeneity within this group. Some studies have shown that "uncoupling of bone" is caused by increased bone resorption.' This may lead to perforation of bone trabeculae, occasionally with an increase in bone fragility greater than that expected from the amount of bone lost. 34 Other studies suggest that the predominant abnormality is the failure of osteoblasts to fill resorbed 6 7 spaces. There is no overall consensus concerning the nature of bone remodelling changes in postmenopausal osteoporosis. Whilst most studies on subjects with idiopathic osteoporosis have demonstrated low bone turnover,38-11 Recker et al I reported trabecular microarchitectural changes associated with normal bone remodelling and Wands et al'2 demonstrated that women with "vertebral crush syndrome" continue to have an inappropriately prolonged phase of increased bone remodelling. Generally, the same principles apply to cortical and trabecular bone loss. 13 14 There is no consensus as to the overall relation between clinically defined patient groups and the changes in bone cell function and matrix that typify the syndrome.
This perplexing diversity of opinion may have arisen because the cellular changes are heterogeneous. Recognition of specific parameters of bone turnover and the nature of the predominant cellular abnormalities in an individual or group of patients may be a more useful way to define osteoporosis, permitting selection of optimum therapy to improve or at least to reduce further deterioration of the biomechanical integrity of the skeleton. To test this hypothesis, we have used histomorphometry to obtain data on bone cell activity and function in 146 19 When tetracycline labelled sections were used, the length of mineralising surface was divided into two components-those with two and those with only one label. The latter represents regions of the bone surface that either finished or started mineralising in the interval between administration of the two labels. To define certain parameters of bone formation more accurately, a corrected value of the length of the mineralising surface was constructed, taking account of single labelling, using the standard method of defining the true active mineralising surface as the double labelled plus half the single labelled surfaces (dLs+ '/2sLs).
Toluidine blue stained sections were used to identify the osteoid surface, defined as an unmineralised surface at least 3 ,um thick.
Osteoid width (O.Wi) was then measured at four equidistant sites on each osteoid seam. All measurements were based on the mean of 20 separate fields using the standard constant for section obliquity (1I2).
Parameters were measured using standard techniques17 [19] [20] [21] and defined according to the terminology proposed by Parfitt et al. 22 The static and dynamic parameters obtained by measurement or calculation are presented in table 1.
Results
All histomorphometric parameters are presented as a mean z-score. A z-score for an individual value is the number of standard deviations by which the value differs from the mean of normal age and sex matched controls for the local population.23 Using the z-score, data from different age groups with different normal values can be pooled. The mean zscore can be calculated for a group as well as an individual. A difference of more than 3 zscore units (that is, 3 SD above or below normal) between the patient groups and controls is regarded as abnormal; any parameter with a z-score between 2 and 3 is classified as moderately abnormal and is only marginally or slightly abnormal if the z-score is between 1 and 2. The parameters are regarded as normal if the z-score is less than 1.
Patients could be divided into five distinct subgroups based on the pattern of overall changes in certain histomorphometric parameters (z-score, factor and cluster analysis). Osteoblast parameters included osteoblast surface, osteoid surface (dLs + ½/2sLs) mineralisation lag time, bone formation rate, and osteoclast parameters included eroded surface, osteoclast number, osteoclast surface, and erosion period (figure). The numeric data for all the patients are presented in tables 2 to 5.
Group 1 comprised 85 (58%) patients. Trabecular bone in this group was charac- 
Units = z-score, above (+) or below (-) the mean. 
50-55 group 2, decreased osteoblastic activity and increased osteoclasis in both trabecular and cortical bone; group 3, marginally increased osteoblastic activity and increased osteoclasis in both trabecular and cortical bone; group 4, decreased osteoblastic and osteoclastic activity in both trabecular and cortical bone; and group 5, no apparent cell abnormality.
The histomorphometric changes in groups 1 and 2 correspond to those described in the two main clinical subclasses of osteoporosis, namely postmenopausal (type 1) and senile (type 2) osteoporosis,l-4 the major difference being that none of our patients fulfilled the clinical criteria for senile osteoporosis. This illustrates that the changes previously described as characteristic of senile osteoporosis are present in one subgroup of patients with postmenopausal osteoporosis. Osteoblast activity was reduced in both groups 1 and 23 4 6 7 but osteoclastic bone resorption was increased in group 2. Although not identical, group 5 in this study corresponds in some respects to the patients described by Recker and Kimmel' and group 3 is similar to those patients described by Melsen et al24 and Christiansen et al. 25 This is, of course, a very general approach to analysis of the data. In cellular terms osteoblastic "activity" is a combination of a number of parameters (cell number, individual cell function, etc.) which can be looked at more closely based on the data collected. For instance, if the bone changes in group 1 are examined more closely, the histomorphometric data on the 76 younger postmenopausal women in this group show that the number of osteoblasts is reduced together with their ability to synthesise matrix. There is also a reduction in the amount of trabecular bone with an associated loss of trabecular integrity, suggesting that a local increase in bone destruction occurred leading to penetration of the trabecular plates. Despite fragmentation of trabeculae, which occurred in 82% of patients, there was no evidence of an increase in osteoclastic activity, suggesting that the pattern of cellular imbalance was different originally and that the pattern of cell changes that ultimately lead to clinically established osteoporosis may vary with time.'0 Histomorphometric data are important for the management of patients with postmenopausal osteoporosis. In group 1 patients osteoblast number and activity are reduced. This is associated with a normal number of poorly functioning osteoclasts. Ideally, therefore, therapy should be directed towards increasing osteoblast recruitment and activity, whilst initially trying to prevent a concomitant increase in osteoclasis.
A similar exercise can be applied to the other groups. The extent of osteoblast dysfunction in group 2 is similar to that in group 1; however, group 2 patients have an increased number of osteoclasts. Although, as in group 1, the activity of individual osteoclasts was suppressed, osteoclasts were able to erode an increased proportion of trabecular surfaces, by virtue of their large numbers. The activation frequency was marginally reduced. Cortical bone parameters in group 2 patients exhibit similar changes to those in trabecular bone.
The most important consequence of these observations is that, at presentation, every patient can be regarded as having a specific cellular abnormality. Ideally, each patient should then receive a tailored treatment regimen. For instance, patients in group 1 are likely to respond positively to therapeutic regimens which promote bone formation, while those in group 2 should respond more favourably if potent antiresorptive agents are included.
These data should also be considered from two other perspectives. Firstly, they are expressed relative to age and sex matched "controls". Should fracture risk be an important end point in osteoporosis, all data (including age and sex matched normals) should be given relative to peak bone mass and its associated parameters. Were this the case, the negative z-scores in the osteoporotic patients would be even larger. Age and sex matched controls have been used here to stress how women with postmenopausal osteoporosis differ from women of the same age without the syndrome because it could be argued that treatment might be aimed at "normalising" a defect rather than at trying to reattain the ideal, as represented by the peak parameters.
Secondly, the approach adopted here for the analysis of osteoporosis is quite different to that used by other authors. There is a longstanding discussion in the literature of the validity of data analysis in patients with type 1 osteoporosis.28 These researchers classified their patients clinically (mainly based on age and clinical characteristics) and then attempted to identify a unified histomorphometric defect to explain bone loss. We believe that the approach adopted in this study is of greater clinical and therapeutic value.
